
1 minute read
Our Next Generation Sequencing panels for solid tumours and haematological malignancies
Our NGS panels have been designed by oncologists for oncologists to cover the most common cancer related genes in solid tumour and haematological malignancies, required for determining treatment pathways:
Full NGS Panel
Core NGS Panel
Bespoke DNA NGS Panel
RNA Pan-Cancer NGS Panel
Single Gene Targeted NGS
Targeted NGS CRC Screen
Full gene sequences for 200 of the most common cancer related genes and chromosome level copy number variation (CNV)
Hotspot/full gene sequences for most common cancer related genes: the essential genes required for determining treatment pathways
Choose from our 200+ gene panel, the most relevant cancer genes, to help determine treatment pathways
Targets 1385 cancer genes for gene expression, variant, and fusion detection with known and novel gene fusion partners, allowing a comprehensive view of cancer pathways. In particular this methodology is used to identify NTRK fusion-positive solid tumours in adults and children to direct the use of Larotrectinib, as per NICE guidance
Hotspot/full gene sequence for a single cancer related gene required for determining treatment pathways
Hotspot/full gene sequence for a CRC related gene (KRAS, NRAS, BRAF) required for determining treatment pathways
Additional Gene Reporting Analysis and reporting of additional cancer related genes from the NGS panel required for determining treatment pathways
Circulating tumour DNA (ctDNA) testing is the process of taking a sample of body fluid (liquid biopsy) and testing it for the presence of tumour DNA, which is shed by tumour cells into the circulation. The Marsden360 assay is used for tumour mutation profiling from a liquid biopsy, for patients with any solid malignant neoplasm. Using highly sensitive Next Generation DNA sequencing (NGS), multiple abberations across multiple genes (74 gene panel, including fusions) can be detected with improved test sensitivity and specificity, resulting in improved clinical outcomes